Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Post-marketing phase IV monitoring study of 紫叶丹胶囊 for chronic hepatitis B
CTR20160533Phase 4Active
- Sponsor
- Beijing Handian Pharmaceutical
- Start
- Sep 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of Ziyedan in Chronic Hepatitis B (CHB), sponsored by Beijing Handian Pharmaceutical. Started Sep 2016; status: active.
02
Drugs
Ziyedan
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on CTR20160533.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20160533.